EN2 is a candidate oncogene in human breast cancer

Oncogene

Volumn 24, Issue 46, 2005, Pages 6890-6901

  Martin, Nicole L ^a   Saba El Leil, Marc K ^a   Sadekova, Svetlana ^b   Meloche, Sylvain ^a   Sauvageau, Guy ^a,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Breast cancer; Engrailed 2; Homeobox; RNAi; Transplantation

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; PROLACTIN; PROTEIN; PROTEIN ENGRAILED 2; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; BREAST CARCINOMA; BREAST TUMOR; CARCINOGENESIS; CELL CONTACT; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; EXPOSURE; FEMALE; HORMONE ACTION; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; DNA PRIMERS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ANIMALIA;

EID: 27144552264     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208840     Document Type: Article

References (39)

1. Al Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. (2003). Proc. Natl. Acad. Sci. USA, 100, 3983-3988.
2. Ball RK, Friis RR, Schoenenberger CA, Doppler W and Groner B. (1988). EMBO J., 7, 2089-2095.
3. Baselga J and Norton L. (2002). Cancer Cell, 1, 319-322.
4. Bieche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R and Vidaud M. (1999). Cancer Res., 59, 2759-2765.
5. Brown AM, Wildin RS, Prendergast TJ and Varmus HE. (1986). Cell, 46, 1001-1009.
6. Cadigan KM and Nusse R. (1997). Genes Dev., 11, 3286-3305.
7. Cella N, Groner B and Hynes NE. (1998). Mol. Cell. Biol., 18, 1783-1792.
8. Danielson KG, Oborn CJ, Durban EM, Butel JS and Medina D. (1984). Proc. Natl. Acad. Sci. USA, 81, 3756-3760.
9. Davis CA, Holmyard DP, Millen KJ and Joyner AL. (1991). Development, 111, 287-298.
10. Davis CA and Joyner AL. (1988). Genes Dev., 2, 1736-1744.
11. DeOme KB, Faulkin LJ, Bern HA and Blair PB. (1959). J. Natl. Cancer Inst., 78, 751-757.
12. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
13. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1512.
14. Huguet EL, McMahon JA, McMahon AP, Bicknell R and Harris AL. (1994). Cancer Res., 54, 2615-2621.
15. Humphreys RC and Rosen JM. (1997). Cell Growth Differ., 8, 839-849.
16. Hutchinson JN and Muller WJ. (2000). Oncogene, 19, 6130-6137.
17. Hynes NE and Stern DF. (1994). Biochim. Biophys. Acta, 1198, 165-184.
18. Ingvarsson S. (1999). Semin. Cancer Biol., 9, 277-288.
19. Joyner AL, Herrup K, Auerbach BA, Davis CA and Rossant J. (1991). Science, 251, 1239-1243.
20. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM and Sauvageau G. (1998). EMBO J., 17, 3714-3725.
21. Krosl J, Baban S, Krosl G, Rozenfeld S, Largman C and Sauvageau G. (1998). Oncogene, 16, 3403-3412.
22. Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K and Largman C. (1995). Exp. Hematol., 23, 1160-1166.
23. Lessard J and Sauvageau G. (2003). Nature, 423, 255-260.
24. Lewis MT. (2000). Breast Cancer Res., 2, 158-169.
25. Liao DJ and Dickson RB. (2000). Endocr. Relat. Cancer, 7, 143-164.
26. Lizard-Nacol S, Lidereau R, Collin F, Arnal M, Hahnel L, Roignot P, Cuisenier J and Guerrin J. (1995). Cancer Res., 55, 4416-4419.
27. McMahon AP, Joyner AL, Bradley A and McMahon JA. (1992). Cell, 69, 581-595.
28. Neckers L and Lee YS. (2003). Nature, 425, 357-359.
29. Nusse R and Varmus HE. (1982). Cell, 31, 99-109.
30. Pawliuk R, Kay R, Lansdorp P and Humphries RK. (1994). Blood, 84, 2868-2877.
31. Peltenburg LT and Murre C. (1996). EMBO J., 15, 3385-3393.
32. Peltenburg LT and Murre C. (1997). Development, 124, 1089-1098.
33. Ross JS, Linette GP, Stec J, Clark E, Ayers M, Leschly N, Symmans WF, Hortobagyi GN and Pusztai L. (2003). Expert Rev. Mol. Diagn., 3, 573-585.
34. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ and Humphries RK. (1994). Proc. Natl. Acad. Sci. USA, 91, 12223-12227.
35. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
36. Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T and Sauvageau G. (1999). Mol. Cell. Biol., 19, 6355-6366.
37. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C and Sorensen PH. (2002). Cancer Cell, 2, 367-376.
38. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T and Varmus HE. (1988). Cell, 55, 619-625.
39. Vaidya AB, Lasfargues EY, Sheffield JB and Coutinho WG. (1978). Virology, 90, 12-22.